Get started

Stocksignal

Binano Genomics Inc - About to take off 🚀 -Bionano is a genome analysis company providing tools and services based on its Saphyr system to scientists and clinicians conducting genetic research and patient testing and providing diagnostic testing for those with autism spectrum disorder (ASD) and other neurodevelopmental disabilities through its Lineagen business. Binano's Saphyr Study Is First to Analyze Cancer Regulation at Level of Single DNA Molecules, Opens Promising New Avenue of Cancer Research. Additionally, Binano's Saphyr appears to be more cost effective. The platform’s estimated cost of $500 per genome coming in far below the $10,000-20,000 per genome when HiFi and SMRT sequencing are put into action. -Its one of our top stocks currently in our portfolio and today we would like to present you our opinions on this boy. Super positive news came previous weeks about Saphyr. Social sentiment on this stock gets more and more positive every day. It started catching good daily volumes. We can see a Bullish Pennant on this chart. We feel very bullish on this one. We wish safe trades to everybody!
NASDAQ:BNGOLong
by caldooninvestment
EZPW Technical Analysis 🧙EZCORP Inc is a United States-based company engaged in offering pawn loans in the United States and Mexico. It also offers short-term unsecured loans and other consumer financial products, and buy and sell second-hand goods. The operating segments of the company are US Pawn, Latin America Pawn, Lana, and other international. US Pawn segment includes all pawn activities in the United States. Latin America Pawn segment includes all pawn activities in Mexico and other parts of Latin America. The company generates revenue from the merchandise sales, jewelry scrapping sales, and pawn service charges, of which key revenue is derived from the merchandise sales which are primarily collateral forfeited from pawn lending operations and used merchandise purchased from the customers. If you understand the idea,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
NASDAQ:EZPWLong
by yura_trades
CRM Technical Analysis 🧙Salesforce.com provides enterprise cloud computing solutions, including Sales Cloud, the company’s main customer relationship management software-as-a-service product. Salesforce.com also offers Service Cloud for customer support, Marketing Cloud for digital marketing campaigns, Commerce Cloud as an e-commerce engine, the Salesforce Platform, which allows enterprises to build applications, and other solutions, such as MuleSoft for data integration. If you understand the idea,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
NYSE:CRMLong
by yura_trades
MA (MASTERCARD INCORPORATED) LONG SET UP (EARNINGS)TITLE/(DATE)- Buy LIMIT MA ASSET- MA PLATFORM- MT4 ORDER TYPE- Market first entry / Buy limit second Time Frame- 1D ENTRY PRICE 1- $314.50 (Market) ENTRY 2- $307.50 (Pending) STOP LOSS- $300.50 (140 PIPs) TAKE PROFIT 1- $328.50 (140 PIPS) TAKE PROFIT 2- $342.50 (280PIPS) TAKE PROFIT 3- $356.50 (420 PIPS) TAKE PROFIT 4- $370.50 (560 PIPS) STATUS: ACTIVE Aug-27-20 Initiated Mizuho Buy $400 Jul-21-20 Resumed Daiwa Securities Neutral $314 Jul-14-20 Initiated Goldman Buy $364
NYSE:MALong
by MavRich_Trading
1
BG - 11.42% Potential Profit - Bullish PennantBullish Pennant breaking out after a 7-month uptrend. Trying to capture the breakout right out of the gate and eventually lock profits well before the target, which I believe to be the best strategy given the period. I am being very selective lately and I only trade when I see very limited risk, with potentially great rewards. This is why I like this setup. There is no clear technical target, this is why I will adjust stop-losses daily (and intraday) based on how the market behaves. - Target Entry $50.59 - Target Stop Loss $50.04 - Target Exit $56.63 About me - P/L September +49.18% | August: +232.32% | No Trades without Analysis - Note that I tend to adjust stop losses in order to secure profits early and preserve capital. This means that the target price is going to be achieved as long as there are no strong pullbacks that trigger my new adjusted stop loss
NYSE:BGLong
by maschera
$SPX SLIGHT PULL BACK BEFORE ANOTHER LEG UP!SLIGHT PULL BACK BEFORE ANOTHER LEG UP --> Will Test Previous Resistance As A Support Price Targets Indicated By The Boxes *Price Movement Likes To Stick On BB Resistance Level On A Bullish Trend LET ME KNOW WHAT YOU THINK! 🧐 💡 IF YOU LIKE MY IDEA, PLEASE HELP AND SUPPORT MY CHANNEL BY HITTING THE THUMBS UP, LEAVING A COMMENT AND FOLLOWING 💯 *You are Welcome to REQUEST CHART ANALYSIS at Anytime! Simply Comment Down Below or DM Me :) ```````````````````````````````````` ⚠ DISCLAIMER: Trading Involves High Risk! I Share My Trading Positions And Ideas With You For FREE BUT Please Be Responsible For All Your Actions. This Chart is Used for Educational Purposes Only And NOT A Recommendation to Buy or Sell the Asset.
TVC:SPX
by crypt0analyst_
6
T - AT&T buy support zones analysisHello traders, Description of the analysis: AT&T corp. ( T ) support zones ideal for timing long positions (gray). Trade what you understand, trade carefully and sparingly according to the business plan. About me: Hi, my name is Jacob Kovarik and I´m trading on stock exchange since 2008. I started with a capital of 3000 USD. My first strategy was based on OTM options. (American stock index and their ETF ). I´ve learnt on my path that professional trading is based on two main fundaments which have to complement each other, to make a bussiness attitude profitable. I´ve tried a lot of techniques and many manners how to analyze the market. From basic technical analysis to fundamental analysis of single title. My analytics gradually changed into professional attitude. I work with logical advantages of stock exchange (return of value back to average, volume , expected volatility , advantage of high stop-loss, the breakdown of time in options, statistics and cosistent thorough control of risk). At the moment, my main target is ITM on SPM index. Biggest part of my current bussiness activity comes from e mini futures (NQ, ES). I´m trader of positions. I´m from Czech republic and I take care of a private fund (over $4.000.000 USD). During my career I´ve earned a lot of valuable experience, such as functionality of strategies and what is more important, control of emotions. Professional trading is, in my opinion, certain kind of mental training and if we are able to control our emotions, accomplishment will show up. I will share with you my analysis and trades on my profile. I wish to all of you successul trades. Jacob
NYSE:TLong
by Jacob_Kovarik
1
MDT - 5.27% Potential Profit - Corridor BreakoutKeeping the Stop Loss at circa -1% in order to preserve capital. All trades have an elevated degree of risk this week. The market can turn anytime. This doesn't mean that we need to stop trading. Corridor broken out after a 3-month correction followed by a promising 3-month bull-run. Indicators are obviously not on our side, since we are playing the bounce. - 3-month Uptrend - RSI + Stoch below 50 (!) - MACD below Signal (!) Target Entry $104.90 Target Stop Loss $103.80 Target Exit $110.41 About me - August P/L: +203.83% | Wins 85.19% | No Trades without Analysis - Note that I tend to adjust stop losses in order to secure profits early and preserve capital. This means that the target price is going to be achieved as long as there are no strong pullbacks that trigger my new adjusted stop loss.
NYSE:MDTLong
by maschera
2
Possible Long Targets Set For SBBPStrongbridge Biopharma Plc operates as a commercial-stage biopharmaceutical company, which focuses on the development and commercialization of therapies for rare diseases. Its pipeline is comprised of Keveyis, Macrilen, Recorlev, and Veldoreotide. The company was founded on May 26, 2015 and is headquartered in Lower Southampton, PA. SHORT INTEREST 1.13M 08/15/19 Average Recommendation: BUY Average Target Price: 13.71 P/E Current 7.53 P/E Ratio (with extraordinary items) 6.21 P/E Ratio (without extraordinary items) 6.51
SLong
by DEXWireNews